● Recruiting

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Condition: CLL · Chronic Lymphocytic Leukemia · Sponsor: BeOne Medicines

PhasePhase 3

Planned participants250

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to investigate the efficacy and safety of BGB-16673 compared with investigator's choice (idelalisib plus rituximab \[for CLL only\] or bendamustine plus rituximab or venetoclax plus rituximab retreatment) in participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) previously exposed to both BTK inhibitors (BTKi) and BCL2 inhibitors (BCL2i).

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · 1.877.828.5568 · clinicaltrials@beonemed.com

Always discuss trial participation with your own doctor first.

Locations (124)

St Bernards Medical Center	Jonesboro, Arkansas, United States	Recruiting
UCLA Department of Medicine Hematologyoncology	Los Angeles, California, United States	Recruiting
Pih Health Whittier Hospital	Whittier, California, United States	Recruiting
Rocky Mountain Cancer Centers (Williams) Usor	Aurora, Colorado, United States	Recruiting
Florida Oncology and Hematology	Fort Myers, Florida, United States	Recruiting
Baptist Md Anderson Cancer Center	Jacksonville, Florida, United States	Recruiting
Cleveland Clinic Florida	Weston, Florida, United States	Recruiting
Emory University Winship Cancer Institute	Atlanta, Georgia, United States	Recruiting
Northside Cancer Center	Atlanta, Georgia, United States	Recruiting
Our Lady of the Lake Hospital	Baton Rouge, Louisiana, United States	Recruiting
American Oncology Partners of Maryland Pa	Bethesda, Maryland, United States	Recruiting
Oncology Hematology Associates	Springfield, Missouri, United States	Recruiting

+ 112 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06846671